In vitro studies demonstrated that β-glucan co-culture with leukocytes such as macrophage and neutrophil could trigger the binding of soluble β-glucan to CD11b on leukocytes, which resulted in the activation of I-domain of CD18 and its binding to iC3b-positive tumor cells. Here, ITGB2 is linked to neoplasm.